IBBQvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with IBBQ, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IBBQ performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IBBQ ETF 2 | +0.10%– | +12.21%– | +15.40%– | +46.91%– | +62.42%– | +32.40%– |
| Flows | IBBQ ETF 2 | +$4M– | +$3M– | +$3M– | +$23M– | +$39M– | +$11M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IBBQ ETF 2 | +22.34%– | +20.29%– | +20.25%– | +21.96%– |
| Max drawdown | IBBQ ETF 2 | -5.97%– | -8.38%– | -23.78%– | -38.09%– |
| Max drawdown duration | IBBQ ETF 2 | 23d– | 48d– | 375d– | 1543d– |
Trading data
IBBQ | ETF 2 | |
Last sale 7/31/2026 at 1:48 PM | $32.27 | – |
| Previous close 07/30/2026 | $32.70 | – |
| Consolidated volume 07/30/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IBBQ | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/31/2026 at 1:48 PM
Live
Closed
IBBQ | ETF 2 | |
|---|---|---|
| Last price | $32.27 | – |
| 1D performance | -1.32% | – |
| AuM | $76.45 M | – |
| E/R | 0.19% | – |
Characteristics
IBBQ | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Invesco | – |
| Benchmark | NASDAQ Biotechnology Index | – |
| N° of holdings | 251 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 9, 2021 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
IBBQ
USA
88.1%
Other
11.9%
ETF 2
Sectors
IBBQ
Healthcare
99.98%
Other
0.02%
ETF 2
Advertisement
Diversification
IBBQ
Total weight of top 15 holdings out of 15
49.38%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
IBBQ
Vertex Pharmaceuticals, Inc.
8.16%
Amgen, Inc.
7.91%
Gilead Sciences, Inc.
7.07%
Regeneron Pharmaceuticals, Inc.
4.62%
Alnylam Pharmaceuticals, Inc.
2.76%
Revolution Medicines, Inc.
2.74%
Biogen, Inc.
2.26%
Illumina, Inc.
1.89%
Moderna, Inc.
1.89%
Royalty Pharma Plc
1.77%
Roivant Sciences Ltd.
1.74%
argenx SE
1.73%
United Therapeutics Corp.
1.63%
Incyte Corp.
1.61%
Insmed, Inc.
1.59%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
